AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research

Conversations from CROI 2015: CDC’s Dr. Jonathan Mermin

IMG_6915

While at the 2015 Conference on Retroviruses and Opportunistic Infections (CROI)  this week, Dr. Ronald Valdiserri, Deputy Assistant Secretary for Health, Infectious Diseases, sat down with Dr. Jonathan Mermin, Director of CDC’s National Center for HIV, Viral Hepatitis, STD, and TB Prevention, to talk about some of the significant scientific findings being discussed here at the meeting….

NIH’s Dr. Carl Dieffenbach Shares Highlights as CROI 2015 Begins (Video)

croi2015_w280x100

As the 2015 Conference on Retroviruses and Opportunistic Infections (CROI) got underway in Seattle yesterday, February 23, we spoke with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID). He discussed what we can anticipate hearing more about during this annual scientific meeting that brings…

Scientific Advances in HIV and HCV To Be Examined Next Week at CROI 2015

AIDS.gov

The 2015 Conference on Retroviruses and Opportunistic Infections (CROI)   takes place next week in Seattle, Washington, and AIDS.gov will be there. This annual scientific meeting of the world’s leading researchers working to understand, prevent, and treat HIV/AIDS, hepatitis C (HCV), Ebola, and related infectious diseases provides a vital forum for translating laboratory and clinical research into…

President’s FY’16 Budget: HIV/AIDS

The White House

Editor’s Note: President Obama released his fiscal year 2016 budget proposal today. The White House issued this fact sheet to highlight the budget’s investment in domestic HIV/AIDS activities across federal departments and agencies. Middle Class Economics: Enhancing the Lives of Americans Living with HIV/AIDS, and Fighting the HIV/AIDS Epidemic The President’s 2016 Budget is designed to…

NIH Announces Funding for New Technologies for Viral Hepatitis

nih logo

The National Institutes of Health (NIH) has issued a funding opportunity announcement (FOA) to encourage small businesses to address viral hepatitis research opportunities delineated in the Action Plan for the Prevention, Care, and Treatment of Viral Hepatitis (Action Plan) [PDF 2MB]. The announcement of a Small Business Innovation Research (SBIR) grant entitled New Technologies for Viral…

2014 Viral Hepatitis Year-in-Review and Looking to 2015

Ronald Valdiserri

2014 has been a year of both opportunities and challenges in the fight against viral hepatitis. In May, the World Health Assembly passed a new resolution  [PDF 151 KB] on viral hepatitis, urging member states to develop and implement coordinated, national strategies for preventing, diagnosing and treating viral hepatitis.  Our nation’s own comprehensive viral hepatitis strategy,…

FDA Commissioner Margaret A. Hamburg’s statement on FDA’s blood donor deferral policy for men who have sex with men

FDA

The U.S. Food and Drug Administration is a science-based regulatory agency that works to protect and promote the public health. In this role, it is our responsibility to regulate the blood supply and to help ensure its continued safety for the patients who receive these life-saving products. Over the past several years, in collaboration with…

FDA approves Viekira Pak to treat hepatitis C

FDA

The U.S. Food and Drug Administration today approved Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with a type of advanced liver disease called cirrhosis. Hepatitis C is a viral disease that causes inflammation of the liver that…